RightFit Trial Directory

Alzheimer's Disease clinical trials in Houston, TX

16 recruiting alzheimer's disease studies with a site in Houston, TX.

All trials in Houston, TX · All Alzheimer's Disease trials

RecruitingPhase 3NCT05980949

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Cypress, TX · DeSoto, TX · El Paso, TX · +145 more sites

RecruitingPhase 3NCT07177352

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Sponsor: Hoffmann-La Roche

Beaumont, TX · Brownsville, TX · Dallas, TX · +65 more sites

RecruitingPhase 2NCT07589595

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Sponsor: Eli Lilly and Company

Beaumont, TX · Dallas, TX · Houston, TX · +39 more sites

RecruitingPhase 2NCT06808984

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Sponsor: Celgene

Austin, TX · Cypress, TX · El Paso, TX · +57 more sites

RecruitingNot applicableNCT07667478

NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE

Sponsor: Chi-Ying (Roy) Lin

Houston, TX

RecruitingPhase 1 / Phase 2NCT07651319

Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease

Sponsor: The Methodist Hospital Research Institute

Houston, TX

RecruitingPhase 3NCT06585787

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Austin, TX · Dallas, TX · DeSoto, TX · +99 more sites

RecruitingPhase 3NCT05511363

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Flower Mound, TX · Frisco, TX · Houston, TX · +56 more sites

RecruitingPhase 3NCT07142954

Epidemiology and Biomarker Study in Alzheimer's Disease

Sponsor: Eli Lilly and Company

Houston, TX

RecruitingPhase 3NCT07602582

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Sponsor: Eli Lilly and Company

Austin, TX · Beaumont, TX · Houston, TX · +49 more sites

RecruitingPhase 1 / Phase 2NCT06775964

Stem Cell Therapy for Early Alzheimer's Disease

Sponsor: Paul E Schulz

Houston, TX

RecruitingPhase not listedNCT06584357

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Sponsor: GAP Innovations, PBC

Beaumont, TX · Houston, TX · +20 more sites

RecruitingPhase not listedNCT05582200

Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease

Sponsor: The Methodist Hospital Research Institute

Houston, TX

RecruitingPhase not listedNCT07157839

Phosphorylated Tau Levels in Donated Blood

Sponsor: The University of Texas Health Science Center, Houston

Houston, TX

RecruitingPhase 2NCT07105709

Open-label Extension Study in Participants With Early Alzheimer's Disease

Sponsor: GlaxoSmithKline

Houston, TX · +8 more sites

Not yet recruitingNot applicableNCT06835283

Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease

Sponsor: Baylor College of Medicine

Houston, TX

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.